ID P94692_DESAF Unreviewed; 1232 AA. AC P94692; DT 01-MAY-1997, integrated into UniProtKB/TrEMBL. DT 01-MAY-1997, sequence version 1. DT 16-JUN-2009, entry version 57. DE SubName: Full=Pyruvate-ferredoxin oxidoreductase; GN Name=por; OS Desulfovibrio africanus. OC Bacteria; Proteobacteria; Deltaproteobacteria; Desulfovibrionales; OC Desulfovibrionaceae; Desulfovibrio. OX NCBI_TaxID=873; RN [1] RP NUCLEOTIDE SEQUENCE. RC STRAIN=NCIB 8401; RX MEDLINE=97440114; PubMed=9294422; RA Pieulle L., Magro V., Hatchikian E.C.; RT "Isolation and analysis of the gene encoding the pyruvate-ferredoxin RT oxidoreductase of Desulfovibrio africanus, production of the RT recombinant enzyme in Escherichia coli, and effect of carboxy-terminal RT deletions on its stability."; RL J. Bacteriol. 179:5684-5692(1997). RN [2] RP NUCLEOTIDE SEQUENCE. RC STRAIN=NCIB 8401; RA Claude H.; RL Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases. RN [3] RP X-RAY CRYSTALLOGRAPHY (2.31 ANGSTROMS) OF 2-1232. RX MEDLINE=99140300; PubMed=10048931; DOI=10.1038/5870; RA Chabriere E., Charon M.H., Volbeda A., Pieulle L., Hatchikian E.C., RA Fontecilla-Camps J.C.; RT "Crystal structures of the key anaerobic enzyme pyruvate:ferredoxin RT oxidoreductase, free and in complex with pyruvate."; RL Nat. Struct. Biol. 6:182-190(1999). RN [4] RP X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 2-1232. RX MEDLINE=21625364; PubMed=11752578; DOI=10.1126/science.1066198; RA Chabriere E., Vernede X., Guigliarelli B., Charon M.H., RA Hatchikian E.C., Fontecilla-Camps J.C.; RT "Crystal structure of the free radical intermediate of RT pyruvate:ferredoxin oxidoreductase."; RL Science 294:2559-2563(2001). CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; Y09702; CAA70873.1; -; Genomic_DNA. DR PDB; 1B0P; X-ray; 2.31 A; A/B=2-1232. DR PDB; 1KEK; X-ray; 1.90 A; A/B=2-1232. DR PDB; 2C3M; X-ray; 1.84 A; A/B=2-1232. DR PDB; 2C3O; X-ray; 2.70 A; A/B=2-1232. DR PDB; 2C3P; X-ray; 2.33 A; A/B=2-1232. DR PDB; 2C3U; X-ray; 2.32 A; A/B=2-1232. DR PDB; 2C3Y; X-ray; 1.93 A; A/B=2-1232. DR PDB; 2C42; X-ray; 1.78 A; A/B=2-1232. DR PDB; 2PDA; X-ray; 3.00 A; A/B=2-1232. DR PDB; 2UZA; X-ray; 2.42 A; A/B=2-1232. DR PDBsum; 1B0P; -. DR PDBsum; 1KEK; -. DR PDBsum; 2C3M; -. DR PDBsum; 2C3O; -. DR PDBsum; 2C3P; -. DR PDBsum; 2C3U; -. DR PDBsum; 2C3Y; -. DR PDBsum; 2C42; -. DR PDBsum; 2PDA; -. DR DIP; DIP:29036N; -. DR GO; GO:0009055; F:electron carrier activity; IEA:InterPro. DR GO; GO:0005506; F:iron ion binding; IEA:InterPro. DR GO; GO:0051536; F:iron-sulfur cluster binding; IEA:InterPro. DR GO; GO:0016903; F:oxidoreductase activity, acting on the alde...; IEA:InterPro. DR GO; GO:0030976; F:thiamin pyrophosphate binding; IEA:InterPro. DR GO; GO:0008152; P:metabolic process; IEA:InterPro. DR InterPro; IPR017896; 4Fe4S_Fe-S-bd. DR InterPro; IPR001450; 4Fe4S_Fe_S_bd_subgr. DR InterPro; IPR017900; 4Fe4S_Fe_S_CS. DR InterPro; IPR019456; Pyrv-flavodox_OxRtase_EKR. DR InterPro; IPR019752; Pyrv/ketoisovalerate_OxRed. DR InterPro; IPR002880; Pyrv_Fd/Flavodoxin_OxRdtase_N. DR InterPro; IPR011895; Pyrv_flavodox_OxRed. DR InterPro; IPR011766; TPP_enzyme_bd_C. DR InterPro; IPR015941; Transketolase_C-like. DR Gene3D; G3DSA:3.40.920.10; Pyrv_Fd/Flavodoxin_OxRdtase; 1. DR Gene3D; G3DSA:3.40.50.920; Transketo_C_like; 1. DR Pfam; PF10371; EKR; 1. DR Pfam; PF00037; Fer4; 2. DR Pfam; PF01558; POR; 1. DR Pfam; PF01855; POR_N; 1. DR Pfam; PF02775; TPP_enzyme_C; 1. DR PIRSF; PIRSF000159; NifJ; 1. DR TIGRFAMs; TIGR02176; pyruv_ox_red; 1. DR PROSITE; PS00198; 4FE4S_FER_1; 2. DR PROSITE; PS51379; 4FE4S_FER_2; 2. PE 1: Evidence at protein level; KW 4Fe-4S; Iron; Iron-sulfur; Metal-binding; Pyruvate. SQ SEQUENCE 1232 AA; 133680 MW; 55D84F536CCFFDBF CRC64; MGKKMMTTDG NTATAHVAYA MSEVAAIYPI TPSSTMGEEA DDWAAQGRKN IFGQTLTIRE MQSEAGAAGA VHGALAAGAL TTTFTASQGL LLMIPNMYKI SGELLPGVFH VTARAIAAHA LSIFGDHQDI YAARQTGFAM LASSSVQEAH DMALVAHLAA IESNVPFMHF FDGFRTSHEI QKIEVLDYAD MASLVNQKAL AEFRAKSMNP EHPHVRGTAQ NPDIYFQGRE AANPYYLKVP GIVAEYMQKV ASLTGRSYKL FDYVGAPDAE RVIVSMGSSC ETIEEVINHL AAKGEKIGLI KVRLYRPFVS EAFFAALPAS AKVITVLDRT KEPGAPGDPL YLDVCSAFVE RGEAMPKILA GRYGLGSKEF SPAMVKSVYD NMSGAKKNHF TVGIEDDVTG TSLPVDNAFA DTTPKGTIQC QFWGLGADGT VGANKQAIKI IGDNTDLFAQ GYFSYDSKKS GGITISHLRF GEKPIQSTYL VNRADYVACH NPAYVGIYDI LEGIKDGGTF VLNSPWSSLE DMDKHLPSGI KRTIANKKLK FYNIDAVKIA TDVGLGGRIN MIMQTAFFKL AGVLPFEKAV DLLKKSIHKA YGKKGEKIVK MNTDAVDQAV TSLQEFKYPD SWKDAPAETK AEPMTNEFFK NVVKPILTQQ GDKLPVSAFE ADGRFPLGTS QFEKRGVAIN VPQWVPENCI QCNQCAFVCP HSAILPVLAK EEELVGAPAN FTALEAKGKE LKGYKFRIQI NTLDCMGCGN CADICPPKEK ALVMQPLDTQ RDAQVPNLEY AARIPVKSEV LPRDSLKGSQ FQEPLMEFSG ACSGCGETPY VRVITQLFGE RMFIANATGC SSIWGASAPS MPYKTNRLGQ GPAWGNSLFE DAAEYGFGMN MSMFARRTHL ADLAAKALES DASGDVKEAL QGWLAGKNDP IKSKEYGDKL KKLLAGQKDG LLGQIAAMSD LYTKKSVWIF GGDGWAYDIG YGGLDHVLAS GEDVNVFVMD TEVYSNTGGQ SSKATPTGAV AKFAAAGKRT GKKDLARMVM TYGYVYVATV SMGYSKQQFL KVLKEAESFP GPSLVIAYAT CINQGLRKGM GKSQDVMNTA VKSGYWPLFR YDPRLAAQGK NPFQLDSKAP DGSVEEFLMA QNRFAVLDRS FPEDAKRLRA QVAHELDVRF KELEHMAATN IFESFAPAGG KADGSVDFGE GAEFCTRDDT PMMARPDSGE ACDQNRAGTS EQQGDLSKRT KK //